BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 96 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $374,012 | +7.4% | 25,955 | +22.4% | 0.00% | – |
| Q2 2023 | $348,268 | +2.1% | 21,210 | +3.9% | 0.00% | – |
| Q1 2023 | $341,135 | +23.3% | 20,415 | +13.9% | 0.00% | – |
| Q4 2022 | $276,660 | +558.7% | 17,930 | +530.7% | 0.00% | – |
| Q3 2022 | $42,000 | +13.5% | 2,843 | +23.6% | 0.00% | – |
| Q2 2022 | $37,000 | -33.9% | 2,300 | -17.9% | 0.00% | – |
| Q1 2022 | $56,000 | -31.7% | 2,800 | -13.0% | 0.00% | – |
| Q4 2021 | $82,000 | +141.2% | 3,220 | +147.7% | 0.00% | – |
| Q3 2021 | $34,000 | -10.5% | 1,300 | 0.0% | 0.00% | – |
| Q2 2021 | $38,000 | +11.8% | 1,300 | 0.0% | 0.00% | – |
| Q1 2021 | $34,000 | +183.3% | 1,300 | +225.0% | 0.00% | – |
| Q4 2020 | $12,000 | +20.0% | 400 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | +25.0% | 400 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | -96.4% | 400 | -96.8% | 0.00% | – |
| Q1 2020 | $224,000 | – | 12,475 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |